Application Information

Application Number : 2024/002327

Application Date : 24-06-2016

Application Type : EPC Fasikül

Grant Number : 2024-GE-139155

Grant Date : 27-02-2024

Registration Number : 2024 002327

Registration Date : 2024-03-21

Protection Type : Patent

European Patent Publication Number (B1) : EP3313441B1

European Patent Application Number : EP16815351.8

Applicants

Person No	Name	Address
7653407	JANSSEN BIOTECH, INC.	800/850 RIDGEVIEW DRIVE HORSHAM, PA 19044 A.B.D.

Inventors

Person No	Name	Address
7653402	Tahamtan AHMADI	1400 MCKEAN ROAD SPRING HOUSE, PENNSYLVANIA 19477 A.B.D.
7653403	Tineke CASNEUF	VU UNIVERSITY MEDICAL CENTER DEPT. OF HEMATOLOGY ROOM PK.X.076 DE BOELELAAN 1117 1081 HV AMSTERDAM HOLLANDA
7653406	Amy SASSER	119 UNION STREET DOYLESTOWN, PENNSYLVANIA 18901 A.B.D.
7653405	Tuna MUTIS	VU UNIVERSITY MEDICAL CENTER DEPT. OF HEMATOLOGY ROOM PK.X.076 DE BOELELAAN 1117 1081 HV AMSTERDAM HOLLANDA
7653404	Henk M LOKHORST	VU UNIVERSITY MEDICAL CENTER DEPT. OF HEMATOLOGY ROOM PK.X.076 DE BOELELAAN 1117 1081 HV AMSTERDAM HOLLANDA

Invention Information

Name Of Invention	İmmün modülasyon ve solid tümörlerin cd38'e spesifik olarak bağlanan antikorlar ile tedavisi.
Summary Of Invention	Mevcut buluş, immün modülasyon ve solid tümörlü hastaların spesifik olarak CD38'i bağlayan antikorlarla tedavi edilmesi yöntemleriyle ilgilidir.

Attorney Information

Name	FULYA SÜMERALP SİMAJ PATENT DAN. LTD. ŞTİ.
Address	HEKİMKÖY SİTESİ 1933 SOK.NO:8 - ÜMİTKÖY/ ANKARA

Priority Information

Classes of The Invention

Patent Application Procedures

Date	Date of Notification	Operation
05-06-2024		Yıllık Ücret Ödeme Talebi
	04-03-2024	Şekli Kontrol Yapıldı. Başvuru / İstem / Fasikül Onaylandı.
26-02-2024		EPO'dan Gelen Patent Fasikül

Publications

Publication Date	Description
21-03-2024	Avrupa Patent Fasiküllerinin İlanı

Payment Dates

Row	Year	Payment Date	Amount Paid (₺)
9	2024	05-06-2024	5190.0